ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference

ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference




ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFDENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 in Miami Beach and will be holding virtual one-on-one meetings. A webcast of the presentation will be available on-demand beginning May 24, 2022 at 7:00 a.m. Eastern time on the Investors section of ENDRA’s website.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with 400,000 cart-based ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

Contacts

Company:
Irina Pestrikova

Senior Director, Finance

investors@endrainc.com
www.endrainc.com

Investor Relations:
Yvonne Briggs

LHA Investor Relations

(310) 691-7100

YBriggs@lhai.com